Dr Elizabeth Plimack discusses prospective immunotherapy in kidney cancer management

At the Thirteenth International Kidney Cancer Symposium, Dr Elizabeth Plimack (Fox Chase Cancer Center, PA) discusses prospective immunotherapy in kidney cancer management. Newer immunotherapeutic agents have demonstrated efficacy and are expected to be approved for kidney cancer soon. Collaborations between different drug manufactures have facilitated progress in combination therapies.

Year of Production:
Running Time:
Color/Sound:

2014
02:45
Color/Sound

Comments are closed.